ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2016 American Transplant Congress

    A P2X7R Mutation with Hypermetabolic T Cells, Th1/Th17 Skewing and Reduced Cardiac Allograft Survival.

    F. D'Addio,1,2 A. Vergani,3 L. Potena,4 A. Maestroni,2 S. Tezza,1 M. Ben Nasr,1 V. Usuelli,2 M. Sbolli,1 L. Borgese,4 A. Iacovoni,5 D. Corradi,6 R. Abdi,7 A. Secchi,2 R. Starling,8 M. Sayegh,7,9 W. Harmon,1 D. Briscoe,1 P. Heeger,10 A. Chandraker,7 F. Grigioni,4 P. Fiorina.1,2

    1Boston Children's Hospital, Boston, MA; 2Ospedale San Raffaele, Milan, Italy; 3Dompe Research, Milan, Italy; 4University of Bologna, Bologna, Italy; 5Ospedale Papa Giovanni XXIII, Bergamo, Italy; 6University of Parma, Parma, Italy; 7Brigham and Women's Hospital, Boston; 8Cleveland Clinic, Cleveland; 9American University of Beirut, Lebanon, Lebanon; 10Icahn School of Medicine at Mount Sinai, New York.

    Background. The purinergic receptor-7 (P2X7R), primarily expressed on lymphocytes, senses ATP released extracellularly during cell damage and regulates T cell activation.Methods. In 640 heart transplant…
  • 2016 American Transplant Congress

    miR-21 in Chronic Allograft Vasculopathy.

    V. Usuelli,1 M. Ben Nasr,1,2 F. D'Addio,1,2 L. Kaifeng,2 L. Borgese,3 L. Potena,3 A. Solini,4 C. Rossi,4 A. Secchi,1 D. Corradi,5 N. Chau,6 P. Fiorina.1,2

    1Ospedale San Raffaele, Milano, Italy; 2Boston Children's Hospital, Boston; 3University of Bologna, Bologna, Italy; 4University of Pisa, Pisa, Italy; 5University of Parma, Parma, Italy; 6Regulus Therapeutics Inc, San Diego.

    Background. Heart transplantation is the most effective therapy to prolong life expectancy in patients with end-stage heart failure. However, despite much progress in the field,…
  • 2016 American Transplant Congress

    A Sustained Viral Response Achieved with Sofosbuvir/Ledipasvir May Increase the Incidence of Acute Cellular Rejection Post Liver Transplantation.

    K. Bortecen, R. Layman, B. Gelb, A. Winnick, G. Morgan, H. Tobias, L. Teperman.

    Transplant Surgery, New York University Langone Medical Center, New York, NY.

    Acute cellular rejection following liver transplantation has decreased in incidence with the use of potent immunosuppressive agents, affecting less than 25 percent of liver transplantation…
  • 2016 American Transplant Congress

    De Novo Anti-HLA DSA Characteristics and Subclinical Antibody Mediated Kidney Allograft Injuries.

    T. Yamamoto, Y. Watarai, A. Takeda, M. Okada, M. Tsujita, T. Hiramitsu, N. Goto, S. Narumi, K. Morozumi, K. Uchida, T. Kobayashi.

    Nagoya daini red cross hospital, Nagoya, Japan.

    Background It has been reported that de novo donor-specific HLA antibody (dn DSA) production is associated with chronic antibody-mediated rejection (CAMR) which leads to poor…
  • 2016 American Transplant Congress

    MicroRNAs in Urinary Sediments as Non-Invasive Tool to Detect Acute Rejection After Kidney Transplantation.

    E. Gielis,1,2 J. Anholts,2 H. de Fijter,3 I. Bajema,4 F. Claas,2 M. Eikmans.2

    1Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium; 2Immunohematology, LUMC, Leiden, Netherlands; 3Nephrology, LUMC, Leiden, Netherlands; 4Pathology, LUMC, Leiden, Netherlands.

    MicroRNAs in urine are suitable targets for non-invasive detection of acute rejection (AR), since they represent relatively stable analytes. Indeed, we found that PCR signals…
  • 2016 American Transplant Congress

    Plasma Alemtuzumab Levels Show Great Interpatient Variability, but Are Not Associated with Late Acute Rejection in Simultaneous Pancreas-Kidney Recipients.

    J. Bank,1 M. Mallat,1 C. Jol-van der Zijde,2 R. Bredius,2 P. van der Boog,1 A. Braat,3 J. Ringers,3 M. Reinders,1 J. de Fijter.1

    1Nephrology, LUMC, Leiden, Netherlands; 2Pediatrics, LUMC, Leiden, Netherlands; 3Surgery, LUMC, Leiden, Netherlands.

    Introduction: Alemtuzumab induction followed by a steroid-free, tacrolimus (Tac) and mycophenolate mofetil (MMF) based regimen effectively prevented acute rejection after simultaneous pancreas-kidney transplantation (SPKT). Acute…
  • 2016 American Transplant Congress

    Post-Transplant Reduction of Long Lived Plasma Cells from Peripheral Circulation Is Associated with Acute Rejection in Kidney Transplant Recipients.

    R. Minz,1 R. Dhital,2 M. Minz,2 R. Nada,3 A. Sharma,2 S. Singh,2 D. Kenwar.2

    1Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India; 2Renal Transplant Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India; 3Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

    Introduction:Plasma cells (PC) are usually defined functionally as antibody secreting cells (ASC). Depending upon their life span, they could either be short lived or long…
  • 2016 American Transplant Congress

    Myeloid-Derived Suppressor Cells (MDSC) Accumulate in Intestinal Transplant (IT) Patients.

    S. Okano,1 K. Hashimoto,1 K. Abu-Elmagd,1 J. Fung,1 D. Kish,2 K. Keslar,2 B. Min,2 R. Fairchild,2 C. Miller.1

    1Transplant Center, Cleveland Clinic, Cleveland, OH; 2Department of Immunology, Lerner Reserch Center, Cleveland Clinic, Cleveland, OH.

    [Background] IT is an efficacious treatment for chronic intestinal failure. Recent advance of immunosuppressive regimens have decreased the rejection rate and improved patient survival. The…
  • 2016 American Transplant Congress

    Assessment of Postoperative Glycemic Control in Orthotopic Heart Transplant Recipients.

    J. Glick Frasiolas, J. Matthew, D. Tsapepas.

    NewYork-Presbyterian Hospital, Columbia University, New York.

    Hyperglycemia may occur after solid organ transplantation because of stress, immunosuppressants, and diabetes mellitus. Glycemic control has been shown to decrease morbidity and mortality in…
  • 2016 American Transplant Congress

    Inflammation Amplifier, a Chemokine Inducer in Non-Immune Cells in Kidney Transplantation Graft.

    H. Higuchi,1,2 H. Bando,2 J. Jing-Jing,2 T. Atsumi,2 D. Iwami,1 K. Morita,1 N. Shinohara,1 M. Murakami.2

    1Renal and Genitourinary Surgery, Hokkaido University, Sapporo, Japan; 2Molecular Neuroimmunology, Institute of Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

    Introduction: Inflammation amplifier (IA), a local chemokine inducer in non-immune cells is induced by the simultaneous activation of NFκB and STATs (IL-17, TNFα, and IL-6)…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences